Cite
HARVARD Citation
Li, Y. et al. (2020). Is nab-paclitaxel better than conventional taxanes as neoadjuvant therapy for breast cancer? A meta-analysis. Journal of international medical research. 48 (8), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Li, Y. et al. (2020). Is nab-paclitaxel better than conventional taxanes as neoadjuvant therapy for breast cancer? A meta-analysis. Journal of international medical research. 48 (8), p. . [Online].